Clinic
Castle Family Health Centers INC.
Castle Family Health Centers INC. was paid $78.67M by Medicaid between Jan 2018 and Dec 2024, across 146 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 77% of everything it billed.
33Billing provider infoCASTLE FAMILY HEALTH CENTERS INC.
ATWATER, CA 95301
ATWATER, CA 95301
33aNPI1639100027assigned 07/05/2006
33bProvider typeRural Health Clinic/Center
28Total paid$78.67M
24GClaims1,366,362
24DCodes billed146
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rural Health Clinic/Center providers in California
Rank by total paid#3 of 215
Median peer was paid$3.62M
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 122,141 | $10.07M | |
| 2019 | 149,914 | $9.75M | |
| 2020 | 190,268 | $11.07M | |
| 2021 | 230,904 | $13.15M | |
| 2022 | 189,138 | $11.03M | |
| 2023 | 289,108 | $12.19M | |
| 2024incomplete | 194,889 | $11.40M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 77% | 384,739 | 327,225 | $60.25M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.0% | 389,956 | 326,934 | $6.30M |
| 00003 | Internal/system code - not a standard HCPCS code | 3.1% | 11,170 | 9,287 | $2.46M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.7% | 41,040 | 38,789 | $1.31M |
| 59425 | 1.4% | 12,486 | 7,105 | $1.08M | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 12,316 | 12,223 | $652K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 7,942 | 7,762 | $447K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 17,021 | 11,815 | $406K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 32,127 | 30,129 | $389K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 5,470 | 5,367 | $387K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 7,077 | 6,922 | $365K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 3,295 | 2,778 | $271K |
134 more codes
| 90791 | Psychiatric diagnostic evaluation | <1% | 3,917 | $266K |
| 92551 | <1% | 20,707 | $260K | |
| 90837 | Psychotherapy session, about an hour | <1% | 4,051 | $249K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 7,778 | $230K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 6,868 | $230K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,090 | $195K |
| 98940 | <1% | 9,076 | $158K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,347 | $152K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,751 | $142K |
| 90686 | <1% | 8,874 | $135K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,611 | $133K |
| 99243 | <1% | 1,504 | $128K | |
| 0002A | <1% | 2,974 | $115K | |
| 0001A | <1% | 2,934 | $102K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 4,568 | $96K |
| 90715 | <1% | 4,268 | $96K | |
| 90651 | <1% | 3,703 | $89K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,480 | $89K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 3,007 | $85K |
| 90670 | <1% | 3,949 | $76K | |
| 99173 | <1% | 20,936 | $76K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 13,080 | $68K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 7,331 | $55K |
| 90648 | <1% | 3,621 | $53K | |
| 0003A | <1% | 1,234 | $49K | |
| 90633 | <1% | 2,997 | $49K | |
| 90734 | <1% | 2,587 | $46K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 9,098 | $45K |
| 59430 | <1% | 499 | $43K | |
| 90620 | <1% | 1,383 | $43K | |
| 81003 | <1% | 32,805 | $39K | |
| 90723 | <1% | 2,737 | $39K | |
| 90716 | <1% | 1,373 | $37K | |
| 85018 | <1% | 27,657 | $36K | |
| 90682 | <1% | 1,253 | $35K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 807 | $35K |
| J3490 | Unclassified drugs | <1% | 503 | $35K |
| 0072A | <1% | 838 | $35K | |
| 0071A | <1% | 816 | $33K | |
| 97814 | <1% | 3,059 | $31K | |
| 90750 | <1% | 169 | $27K | |
| 90710 | <1% | 1,511 | $27K | |
| 90707 | <1% | 1,081 | $25K | |
| 90696 | <1% | 1,380 | $24K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 7,459 | $23K |
| 92250 | <1% | 2,469 | $22K | |
| 97813 | <1% | 3,001 | $21K | |
| 90680 | <1% | 1,466 | $19K | |
| G9920 | Screening performed and negative | <1% | 947 | $19K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,209 | $16K |
| 90700 | <1% | 866 | $16K | |
| 81025 | <1% | 6,638 | $14K | |
| 93000 | <1% | 524 | $14K | |
| 92083 | <1% | 1,306 | $13K | |
| 90677 | <1% | 332 | $12K | |
| 99383 | <1% | 129 | $12K | |
| 81002 | <1% | 14,837 | $11K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 75 | $11K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,912 | $8K |
| 99381 | <1% | 157 | $8K | |
| 92133 | <1% | 570 | $8K | |
| 0031A | <1% | 227 | $7K | |
| 90656 | <1% | 648 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 188 | $7K |
| 90619 | <1% | 472 | $5K | |
| 90647 | <1% | 452 | $5K | |
| 92015 | Determination of refractive state | <1% | 10,798 | $5K |
| 0013A | <1% | 114 | $5K | |
| 0053A | <1% | 70 | $4K | |
| 0124A | <1% | 87 | $4K | |
| 90671 | <1% | 244 | $3K | |
| 99384 | <1% | 24 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 252 | $2K |
| 90673 | <1% | 75 | $2K | |
| 0052A | <1% | 34 | $2K | |
| 90732 | <1% | 24 | $2K | |
| 99242 | <1% | 22 | $2K | |
| 92134 | <1% | 617 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 55 | $2K |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 194 | $2K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 142 | $1K |
| 87807 | <1% | 306 | $1K | |
| Q3014 | Telehealth originating site facility fee | <1% | 41 | $1K |
| 92002 | <1% | 16 | $1K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 149 | $1K |
| 92557 | <1% | 12 | $1K | |
| 92567 | <1% | 25 | $1K | |
| 86580 | <1% | 322 | $1K | |
| 90681 | <1% | 63 | $1K | |
| 82962 | <1% | 544 | $926.21 | |
| 0054A | <1% | 14 | $871.00 | |
| 90672 | <1% | 56 | $792.00 | |
| 90662 | <1% | 64 | $585.00 | |
| 97810 | <1% | 55 | $561.54 | |
| 69210 | <1% | 19 | $530.00 | |
| 76514 | <1% | 73 | $492.68 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 65 | $488.97 |
| 0121A | <1% | 13 | $469.00 | |
| 91320 | <1% | 35 | $393.30 | |
| 97811 | <1% | 30 | $355.27 | |
| 83655 | <1% | 21 | $223.23 | |
| 99188 | <1% | 185 | $148.00 | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 1,261 | $144.00 |
| 92020 | <1% | 15 | $134.01 | |
| 90480 | <1% | 12 | $120.00 | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 41 | $38.52 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 341 | $17.68 |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 94 | $4.30 |
| 3075F | 0% | 4,475 | $0.00 | |
| Z1032 | 0% | 346 | $0.00 | |
| Z1034 | 0% | 12,224 | $0.00 | |
| 3079F | 0% | 9,112 | $0.00 | |
| 3074F | 0% | 23,164 | $0.00 | |
| 3044F | 0% | 655 | $0.00 | |
| 3008F | 0% | 18,188 | $0.00 | |
| 2001F | 0% | 18,193 | $0.00 | |
| 3080F | 0% | 2,309 | $0.00 | |
| 1036F | 0% | 20,008 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 220 | $0.00 |
| Z1038 | 0% | 81 | $0.00 | |
| 3052F | 0% | 172 | $0.00 | |
| 3048F | 0% | 92 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 42 | $0.00 |
| S0257 | Counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service) | 0% | 45 | $0.00 |
| 0011A | 0% | 25 | $0.00 | |
| 3077F | 0% | 5,140 | $0.00 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 0% | 455 | $0.00 |
| 3051F | 0% | 218 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 500 | $0.00 |
| 3078F | 0% | 21,711 | $0.00 | |
| 3046F | 0% | 479 | $0.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 121 | $0.00 |
| 90461 | 0% | 14 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLUJANO, EDWARD (CEO)
| Provider | Location | Paid |
|---|---|---|
| Castle Family Health Centers INC. | Winton, CA | $16.82M |
| Castle Family Health Centers INC. | Atwater, CA | $12.06M |
| Castle Family Health Centers INC | Atwater, CA | $146K |
| Castle Family Health Centers INC | Atwater, CA | $98K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.